Table 3.
Patient Characteristics at the Baseline Test, Stratified by Infection-Unrelated Cancer Diagnosis
| Breast Cancer | Colorectal Cancer | Connective Tissue Cancer | Lung Cancer | Melanoma | Esophageal Cancer | Prostate Cancer | Other Infection-Unrelated Cancersa | |
|---|---|---|---|---|---|---|---|---|
| n | 1873 | 384 | 107 | 415 | 151 | 370 | 440 | 1537 |
| Female | 1850 (98.8) | 223 (58.1) | 59 (55.1) | 117 (28.2) | 89 (58.9) | 166 (44.9) | 0 (0.0) | 923 (60.1) |
| Median [IQR] age, years | 41.10 [34.18, 48.61] | 45.18 [36.16, 53.18] | 39.01 [31.22, 48.80] | 49.19 [43.56, 55.11] | 45.45 [37.55, 53.37] | 48.99 [42.59, 55.13] | 55.58 [50.46, 60.26] | 43.53 [34.39, 51.70] |
| Calendar period | ||||||||
| 2004–2007 | 896 (47.8) | 159 (41.4) | 55 (51.4) | 183 (44.1) | 67 (44.4) | 175 (47.3) | 173 (39.3) | 726 (47.2) |
| 2008–2011 | 886 (47.3) | 194 (50.5) | 47 (43.9) | 198 (47.7) | 77 (51.0) | 173 (46.8) | 235 (53.4) | 721 (46.9) |
| 2012–2014 | 91 (4.9) | 31 (8.1) | 5 (4.7) | 34 (8.2) | 7 (4.6) | 22 (5.9) | 32 (7.3) | 90 (5.9) |
| Median [IQR] CD4 cell count (cells/µL) | 291 [165, 452] | 259 [155, 385] | 248 [105, 430] | 238 [124, 405] | 233 [133, 374] | 244 [121, 387] | 244 [129, 401] | 251 [131, 410] |
| CD4 cell count (cells/µL) | ||||||||
| <50 | 115 (6.1) | 24 (6.2) | 8 (7.5) | 27 (6.5) | 12 (7.9) | 19 (5.1) | 27 (6.1) | 102 (6.6) |
| 50–99 | 118 (6.3) | 19 (4.9) | 14 (13.1) | 36 (8.7) | 12 (7.9) | 43 (11.6) | 39 (8.9) | 137 (8.9) |
| 100–199 | 287 (15.3) | 75 (19.5) | 21 (19.6) | 88 (21.2) | 32 (21.2) | 73 (19.7) | 84 (19.1) | 316 (20.6) |
| 200–349 | 483 (25.8) | 111 (28.9) | 18 (16.8) | 100 (24.1) | 37 (24.5) | 90 (24.3) | 104 (23.6) | 345 (22.4) |
| 350–499 | 323 (17.2) | 56 (14.6) | 15 (14.0) | 52 (12.5) | 20 (13.2) | 50 (13.5) | 64 (14.5) | 215 (14.0) |
| 500–699 | 187 (10.0) | 34 (8.9) | 11 (10.3) | 37 (8.9) | 9 (6.0) | 34 (9.2) | 42 (9.5) | 147 (9.6) |
| ≥700 | 124 (6.6) | 10 (2.6) | 7 (6.5) | 23 (5.5) | 10 (6.6) | 11 (3.0) | 20 (4.5) | 81 (5.3) |
| Missing | 236 (12.6) | 55 (14.3) | 13 (12.1) | 52 (12.5) | 19 (12.6) | 50 (13.5) | 60 (13.6) | 194 (12.6) |
Data are presented as n or n (%) unless otherwise indicated.
Abbreviation: IQR, interquartile range.
aIncludes all infection-unrelated cancers not shown in the other columns.